Sawai Announces Listing of a single Generic Drug with Two Strengths

Dec. 07. 2023

Osaka, Japan – December 7, 2023 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Motohiko Kimura) today announced the listing of a single generic drug with two strengths in the NHI (National Health Insurance) drug price list. Sawai’s product line now includes 332 compounds with 806 strengths.

The list of new products

1. Lenalidomide Capsules

Generic name Lenalidomide
Strengths 2.5mg, 5mg
Brand products Revlimid® Capsules 2.5mg, 5mg


The products announced in this press release are not approved by the Food & Drug Administration for sale and distribution in the United States.